Cannabis extract outperformed pure CBD at reducing brain immune cell inflammation through multiple molecular pathways

The cannabis extract significantly reduced pro-inflammatory cytokines IL-1β, IL-6, and TNF-α in activated microglia, while pure CBD only partially reduced them and beta-caryophyllene was ineffective. The extract's effects were only partially dependent on CB2 receptors and also involved regulation of endocannabinoid-metabolizing enzymes, inhibition of reactive oxygen species, and suppression of NF-κB nuclear translocation via JNK/p38 modulation.

BV-2 microglial cells were pretreated with a CBD-and-terpene-enriched cannabis extract, pure CBD, or beta-caryophyllene, then stimulated with LPS (lipopolysaccharide) to induce inflammation. Multiple inflammatory pathways and signaling cascades were measured.

This study provides molecular evidence for why whole cannabis extracts may be more effective than isolated CBD for neuroinflammation, supporting the entourage effect hypothesis with specific mechanistic data.

Neuroinflammation is implicated in conditions from Alzheimer's to depression. If whole cannabis extracts are more effective than isolated cannabinoids at controlling brain inflammation, this has implications for how cannabis-based neurotherapeutics are developed.

In vitro study using a cell line, not primary microglia or whole-brain tissue. The specific extract composition may not represent all commercial products. Concentrations used may not reflect achievable brain levels. No in vivo validation.